Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
248 words
In a process for automated radioassay of a ligand sample by flowing the sample through a chamber containing an immobilized binder composed of a solid substrate and binder specific to the ligand and wherein the sample contains proteins tending to plug the substrate, the improvement comprising: diluting the sample to a consistency for free unplugged flow through the immobilized binder; preincubating the sample with a binder specific to the ligand in said sample being assayed together with a known amount of a radioactive labeled ligand to form a mixture including (a) unlabeled ligand bound to the binder, (b) labeled ligand bound to the binder, (c) free unbound unlabeled ligand, and (d) free unbound labeled ligand; providing a chamber containing a binder specific to the ligand supported on a solid substrate to bind free unbound labeled and unlabeled ligand; flowing said mixture through said chamber to bind free unbound labeled and unlabeled ligand to the solid supported binder in the chamber with the bound labeled and unlabeled ligand passing through the chamber; flowing an eluting solution through said chamber to effect release of labeled and unlabeled ligand from the solid supported binder in the chamber; counting the radioactivity of at least one or both of the labeled ligand which passed through the chamber and the labeled ligand eluted from the chamber to determine the quantity of the ligand sought to be assayed in said sample; and rinsing the chamber for subsequent assays of other samples of the same ligand.
Claim 2
Dependent Claim
248 words
In a process for automated radioassay of a ligand sample by flowing the sample through a chamber containing an immobilized binder composed of a solid substrate and binder specific to the ligand and wherein the sample contains proteins tending to plug the substrate, the improvement comprising: diluting the sample to a consistency for free unplugged flow through the immobilized binder; preincubating the sample with a binder specific to the ligand in said sample being assayed together with a known amount of a radioactive labeled ligand to form a mixture including (a) unlabeled ligand bound to the binder, (b) labeled ligand bound to the binder, (c) free unbound unlabeled ligand, and (d) free unbound labeled ligand; providing a chamber containing a binder specific to the ligand supported on a solid substrate to bind free unbound labeled and unlabeled ligand; flowing said mixture through said chamber to bind free unbound labeled and unlabeled ligand to the solid supported binder in the chamber with the bound labeled and unlabeled ligand passing through the chamber; flowing an eluting solution through said chamber to effect release of labeled and unlabeled ligand from the solid supported binder in the chamber; counting the radioactivity of at least one or both of the labeled ligand which passed through the chamber and the labeled ligand eluted from the chamber to determine the quantity of the ligand sought to be assayed in said sample; and rinsing the chamber for subsequent assays of other samples of the same ligand.
Claim 3
Dependent Claim
21 words
In a process as set forth in claim 1 wherein said sample is serum containing proteins tending to plug said chamber.
Claim 4
Dependent Claim
11 words
The process of claim 1 wherein the ligand is folic acid.
Claim 5
Dependent Claim
13 words
The process of claim 1 wherein the ligand is vitamin B 12 .
Claim 6
Dependent Claim
34 words
In a process as set forth in claim 1 wherein said pre-incubation is conducted for a period of time sufficient to establish an equilibrium between the labeled and unlabeled ligand bound to the binder.
Claim 7
Dependent Claim
17 words
In a process as set forth in claim 1 wherein the solid substrate is a particulate substrate.
Claim 8
Dependent Claim
183 words
A process for the direct radioimmunoassay of T 3 antigen in a serum sample comprising the steps of preincubating a binder specific to T 3 antigen in the presence of radioactive labeled T 3 antigen and unlabeled T 3 antigen sample to form a mixture including (a) unlabeled T 3 bound to the binder, (b) labeled T 3 bound to the binder, (c) free unbound unlabeled T 3 , and (d) free unbound labeled T 3 ; passing said mixture through a chamber containing a binder specific to T 3 supported on a solid substrate to effect binding of the free unbound labeled and unlabeled T 3 to the supported binder while said bound labeled and unlabeled T 3 passes through said chamber; flowing an eluting solution through said chamber to effect release of the labeled and unlabeled T 3 bound to the supported binder in the chamber; counting the radioactivity of at least one of the labeled T 3 which passed through the chamber or labeled T 3 eluted from the chamber to determine the quantity of T 3 in said serum.
Claim 9
Dependent Claim
183 words
A process for the direct radioimmunoassay of T 3 antigen in a serum sample comprising the steps of preincubating a binder specific to T 3 antigen in the presence of radioactive labeled T 3 antigen and unlabeled T 3 antigen sample to form a mixture including (a) unlabeled T 3 bound to the binder, (b) labeled T 3 bound to the binder, (c) free unbound unlabeled T 3 , and (d) free unbound labeled T 3 ; passing said mixture through a chamber containing a binder specific to T 3 supported on a solid substrate to effect binding of the free unbound labeled and unlabeled T 3 to the supported binder while said bound labeled and unlabeled T 3 passes through said chamber; flowing an eluting solution through said chamber to effect release of the labeled and unlabeled T 3 bound to the supported binder in the chamber; counting the radioactivity of at least one of the labeled T 3 which passed through the chamber or labeled T 3 eluted from the chamber to determine the quantity of T 3 in said serum.